REPL
Price
$13.07
Change
+$0.20 (+1.55%)
Updated
Sep 18 closing price
Capitalization
1.23B
39 days until earnings call
Intraday BUY SELL Signals
RVMD
Price
$190.95
Change
-$5.99 (-3.04%)
Updated
Sep 18 closing price
Capitalization
40.93B
52 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

REPL vs RVMD

REPL vs RVMD Comparison Chart in %
View a ticker or compare two or three
VS
REPL vs. RVMD commentary
Sep 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REPL is a Hold and RVMD is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVMD($40.9B) has a higher market cap than REPL($1.23B). RVMD YTD gains are higher at: 139.736 vs. REPL (34.465). REPL has higher annual earnings (EBITDA): -284.22M vs. RVMD (-1.69B). RVMD has more cash in the bank: 3.94B vs. REPL (195M). REPL has less debt than RVMD: REPL (112M) vs RVMD (642M). REPL (0) and RVMD (0) have equivalent revenues.
REPLRVMDREPL / RVMD
Capitalization1.23B40.9B3%
EBITDA-284.22M-1.69B17%
Gain YTD34.465139.73625%
P/E RatioN/AN/A-
Revenue00-
Total Cash195M3.94B5%
Total Debt112M642M17%
FUNDAMENTALS RATINGS
REPL vs RVMD: Fundamental Ratings
REPL
RVMD
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
95
Overvalued
PROFIT vs RISK RATING
1..100
1002
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
3535
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
4250

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

REPL's Valuation (54) in the Biotechnology industry is somewhat better than the same rating for RVMD (95) in the null industry. This means that REPL’s stock grew somewhat faster than RVMD’s over the last 12 months.

RVMD's Profit vs Risk Rating (2) in the null industry is significantly better than the same rating for REPL (100) in the Biotechnology industry. This means that RVMD’s stock grew significantly faster than REPL’s over the last 12 months.

RVMD's SMR Rating (98) in the null industry is in the same range as REPL (99) in the Biotechnology industry. This means that RVMD’s stock grew similarly to REPL’s over the last 12 months.

RVMD's Price Growth Rating (35) in the null industry is in the same range as REPL (35) in the Biotechnology industry. This means that RVMD’s stock grew similarly to REPL’s over the last 12 months.

RVMD's P/E Growth Rating (100) in the null industry is in the same range as REPL (100) in the Biotechnology industry. This means that RVMD’s stock grew similarly to REPL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
REPLRVMD
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
75%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
70%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
73%
Advances
ODDS (%)
Bullish Trend 19 days ago
76%
Bullish Trend 7 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 5 days ago
68%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
89%
Aroon
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
86%
COMPARISON
Comparison
Sep 20, 2026
Stock price -- (REPL: $13.07 vs. RVMD: $190.95)
Brand notoriety: REPL and RVMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: REPL: 48% vs. RVMD: 417%
Market capitalization -- REPL: $1.23B vs. RVMD: $40.93B
REPL [@Biotechnology] is valued at $1.23B. RVMD’s [@Biotechnology] market capitalization is $40.93B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $128.84B. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

REPL’s FA Score shows that 0 FA rating(s) are green while RVMD’s FA Score has 1 green FA rating(s).

  • REPL’s FA Score: 0 green, 5 red.
  • RVMD’s FA Score: 1 green, 4 red.
According to our system of comparison, RVMD is a better buy in the long-term than REPL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

REPL’s TA Score shows that 4 TA indicator(s) are bullish while RVMD’s TA Score has 5 bullish TA indicator(s).

  • REPL’s TA Score: 4 bullish, 4 bearish.
  • RVMD’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, RVMD is a better buy in the short-term than REPL.

Price Growth

REPL (@Biotechnology) experienced а +1.16% price change this week, while RVMD (@Biotechnology) price change was -6.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.53%. For the same industry, the average monthly price growth was -8.46%, and the average quarterly price growth was +7.13%.

Reported Earning Dates

REPL is expected to report earnings on Oct 29, 2026.

RVMD is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (+1.53% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
REPL
Daily Signal:
Gain/Loss:
RVMD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTXSX65.700.16
+0.24%
FullerThaler Behavioral Sm-Cp GrInstl
IBLLX36.38-0.02
-0.05%
Transamerica Multi-Managed Balanced C
RLBEX40.06-0.06
-0.15%
American Funds American Balanced R-4
TCVYX26.50-0.13
-0.49%
Touchstone Mid Cap Value Y
JARSX15.51-0.14
-0.89%
Easterly Global Real Estate R6